Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02967432 · ClinicalTrials.gov registry record · Phase 2
Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU
A Phase 2 study of Staphylococcus, sponsored by Crouse Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 216
- Enrollment target
- 1
- Study location
NCT02967432: Completed Phase 2 study of Staphylococcus, sponsored by Crouse Hospital.
NCT02967432 is a Phase 2 study of Staphylococcus that has completed, run by Crouse Hospital. The registered enrollment target is 216 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02967432, a Phase 2 study of Staphylococcus, has completed, sponsored by Crouse Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 216 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether or not mupirocin treatment results in S. aureus decolonization in affected NICU patients.
Primary Outcome
Compare the number of S. aureus patient colonization days between treatment versus control group
Conditions Studied
Interventions
- DRUG Mupirocin Topical Ointment
- DRUG Petroleum Jelly
Study Locations (1)
New York
- Crouse Hospital - Neonatal Intensive Care Unit - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-12 |
| Phase | Phase 2 |
What the finished NCT02967432 record still lists
NCT02967432 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% higher).
The record links to 1 condition, with Staphylococcus appearing as the primary indexed condition, and to 2 interventions - of which Mupirocin Topical Ointment is the first listed.
NCT02967432 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02967432 about?
NCT02967432 is a clinical study titled "Mupirocin to Reduce Staphylococcus Aureus Colonization in Infants Hospitalized in a NICU". The purpose of this study is to determine whether or not mupirocin treatment results in S. aureus decolonization in affected NICU patients.
What is the current status of trial NCT02967432?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 216 participants. The study started on 2016-10. Estimated completion is 2019-12.
What conditions does trial NCT02967432 study?
This clinical trial studies the following conditions: Staphylococcus.
What interventions are being tested in trial NCT02967432?
The interventions under investigation include: Mupirocin Topical Ointment (DRUG), Petroleum Jelly (DRUG).
Who is sponsoring clinical trial NCT02967432?
This trial is sponsored by Crouse Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02967432 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02967432's enrollment target sits among peer trials
216 286th of 2000 higher than 1,712 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia